C6orf47_D17H6S53E activators represent a specialized category of chemicals that interact specifically with the protein encoded by the C6orf47 gene, also referred to by its alternative designation D17H6S53E. These activators are distinguished by their ability to modulate the activity of this protein, enhancing its functional role within cellular processes. The protein in question is a part of intricate cellular signaling pathways, contributing to various biochemical reactions and cellular functions. The activators of C6orf47_D17H6S53E play a pivotal role in influencing these pathways, thereby affecting the protein's activity levels. These chemicals are characterized by their unique molecular structures, which are designed to bind specifically to this protein, facilitating an increase in its natural activity. This binding is highly selective, ensuring that the activation is targeted and efficient, with minimal impact on unrelated proteins or pathways.
The development and study of C6orf47_D17H6S53E activators are rooted in an in-depth understanding of the protein's structure and function, alongside the signaling pathways it is involved in. Researchers focus on the molecular interaction between the activators and the protein, aiming to elucidate the mechanism of action that leads to the enhanced activity of C6orf47_D17H6S53E. This involves comprehensive biochemical and biophysical analyses to determine how these chemicals influence the protein's conformation and its interaction with other molecules within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor. If C6orf47 is associated with Rho/ROCK signaling, then Y-27632 can influence the protein by suppressing ROCK-mediated effects. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. If C6orf47 operates within or is influenced by the JNK pathway, SP600125 would influence its activity by attenuating JNK signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PKC activator. If C6orf47 has any association with PKC-related signaling, PMA would impact its activity by enhancing PKC-mediated effects. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Gamma-secretase inhibitor influencing the Notch pathway. Depending on C6orf47's involvement in Notch signaling, DAPT could modulate its activity. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB pathway inhibitor. If C6orf47 functions within or is influenced by NF-κB signaling, Bay 11-7082 can modulate its activity by suppressing NF-κB-mediated effects. | ||||||